_version_ 1783533960415936512
author Borrelli, Mimi R.
Garcia, Julia
Griffin, Michelle
Deleon Diaz, Nestor M.
Moore, Alexandra L.
Mascharak, Shamik
Duoto, Bryan
desJardins-Park, Heather
Adem, Sandeep
Lerbs, Tristan
Gastou, Marc
Cui, Lui
Januszyk, Michael
Lorenz, Hermann P.
Wan, Derrick C.
Gurtner, Geoffrey C.
Chang, Howard
Wernig, Gerlinde
Longaker, Michael T.
author_facet Borrelli, Mimi R.
Garcia, Julia
Griffin, Michelle
Deleon Diaz, Nestor M.
Moore, Alexandra L.
Mascharak, Shamik
Duoto, Bryan
desJardins-Park, Heather
Adem, Sandeep
Lerbs, Tristan
Gastou, Marc
Cui, Lui
Januszyk, Michael
Lorenz, Hermann P.
Wan, Derrick C.
Gurtner, Geoffrey C.
Chang, Howard
Wernig, Gerlinde
Longaker, Michael T.
author_sort Borrelli, Mimi R.
collection PubMed
description
format Online
Article
Text
id pubmed-7224736
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-72247362020-06-15 Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations Borrelli, Mimi R. Garcia, Julia Griffin, Michelle Deleon Diaz, Nestor M. Moore, Alexandra L. Mascharak, Shamik Duoto, Bryan desJardins-Park, Heather Adem, Sandeep Lerbs, Tristan Gastou, Marc Cui, Lui Januszyk, Michael Lorenz, Hermann P. Wan, Derrick C. Gurtner, Geoffrey C. Chang, Howard Wernig, Gerlinde Longaker, Michael T. Plast Reconstr Surg Glob Open PSRC Abstract Supplement Wolters Kluwer Health 2020-05-13 /pmc/articles/PMC7224736/ http://dx.doi.org/10.1097/01.GOX.0000667800.90500.3c Text en Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle PSRC Abstract Supplement
Borrelli, Mimi R.
Garcia, Julia
Griffin, Michelle
Deleon Diaz, Nestor M.
Moore, Alexandra L.
Mascharak, Shamik
Duoto, Bryan
desJardins-Park, Heather
Adem, Sandeep
Lerbs, Tristan
Gastou, Marc
Cui, Lui
Januszyk, Michael
Lorenz, Hermann P.
Wan, Derrick C.
Gurtner, Geoffrey C.
Chang, Howard
Wernig, Gerlinde
Longaker, Michael T.
Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations
title Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations
title_full Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations
title_fullStr Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations
title_full_unstemmed Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations
title_short Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations
title_sort abstract 186: cd36 antagonism minimizes skin scarring by inhibiting jun-dependent fibrotic pathways within fibrogenic fibroblast subpopulations
topic PSRC Abstract Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224736/
http://dx.doi.org/10.1097/01.GOX.0000667800.90500.3c
work_keys_str_mv AT borrellimimir abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT garciajulia abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT griffinmichelle abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT deleondiaznestorm abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT moorealexandral abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT mascharakshamik abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT duotobryan abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT desjardinsparkheather abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT ademsandeep abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT lerbstristan abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT gastoumarc abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT cuilui abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT januszykmichael abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT lorenzhermannp abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT wanderrickc abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT gurtnergeoffreyc abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT changhoward abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT werniggerlinde abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations
AT longakermichaelt abstract186cd36antagonismminimizesskinscarringbyinhibitingjundependentfibroticpathwayswithinfibrogenicfibroblastsubpopulations